Active, Not Recruiting
Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma
NCT03959293
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +7 more
- Locations
-
- Ch - Centre Hospitalier Abbeville, France
- Ch - Hôpital Claude Bernard Albi, France
- Chu - Hôpital Sud Amiens, France
- Privé - Clinique de L'Europe Amiens, France